{"transactions":[{"id":2076608,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-23T22:31:27.000Z","date":"2022-12-21","kind":"disposition_to_issuer","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 21, 2022, the reporting person and the Issuer determined to rescind 40,000 vested shares of restricted common stock originally granted to the reporting person on April 16, 2021.  The vesting of the remaining restricted shares remains unchanged with 1/12 vesting on the first day of each quarterly anniversary of the grant, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 21, 2022, the reporting person and the Issuer determined to rescind 40,000 vested shares of restricted common stock originally granted to the reporting person on April 16, 2021.  The vesting of the remaining restricted shares remains unchanged with 1/12 vesting on the first day of each quarterly anniversary of the grant, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continued service with the Issuer."}],"balance_after":164089,"source":{"system":"sec-edgar","filing":"0001567619-22-022001","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000156761922022001/doc1.xml","form_type":"4"}},{"id":2746695,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-16T20:51:42.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":187804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares. The restricted shares have the following accelerated vesting conditions: (1) The consummation of a Sale Event. (2) The closing price of the Company's stock price is equal or greater than forty dollars per share ($40) for two consecutive trading days. (3) The Grantee's service with the Company or a Related Entity is terminated by the Company without Cause (as defined below). The restricted shares vest as follows, and have no voting or dispositive rights until vested:  1/3 on April 16, 2022, and 1/12 on the first day of each quarter thereafter, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continuing employment with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted shares. The restricted shares have the following accelerated vesting conditions: (1) The consummation of a Sale Event. (2) The closing price of the Company's stock price is equal or greater than forty dollars per share ($40) for two consecutive trading days. (3) The Grantee's service with the Company or a Related Entity is terminated by the Company without Cause (as defined below). The restricted shares vest as follows, and have no voting or dispositive rights until vested:  1/3 on April 16, 2022, and 1/12 on the first day of each quarter thereafter, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continuing employment with the Issuer."}],"balance_after":204089,"source":{"system":"sec-edgar","filing":"0001567619-21-008229","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000156761921008229/doc1.xml","form_type":"4"}},{"id":3111495,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true}}],"security":"Employee Stock Option Grant","published_at":"2020-06-12T21:42:33.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% vest on June 7, 2021, subject to the Grantee's continued service as a director on such dates."}],"balance_after":20038,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-20-006582","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000165495420006582/section16.xml","form_type":"4"}},{"id":3111494,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-06-12T21:42:33.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares. 100% vest on June 7, 2021, subject to the Grantee's continued service as a director on such dates."}],"balance_after":162840,"source":{"system":"sec-edgar","filing":"0001654954-20-006582","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000165495420006582/section16.xml","form_type":"4"}},{"id":3782187,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-26T23:47:34.000Z","date":"2018-10-24","kind":"grant","acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares which vest on October 24, 2028, subject to earlier vesting in certain situations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Aggregate amount indicated reflects 20-for-1 reverse split and includes additional 2,663 post-split restricted shares previously issued."}],"balance_after":152840,"source":{"system":"sec-edgar","filing":"0001213900-18-014528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000121390018014528/ownership.xml","form_type":"4"}},{"id":4167253,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-10T00:01:10.000Z","date":"2017-11-07","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted shares that vest on November 7, 2027, subject to earlier vesting in certain situations."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares that vest on November 7, 2027, subject to earlier vesting in certain situations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of these shares, 3,250 are restricted shares that vest on July 12, 2026, subject to earlier vesting in certain situations."}],"balance_after":56771,"source":{"system":"sec-edgar","filing":"0001213900-17-011707","document":"f4110717cantrell_aytubio.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000121390017011707/f4110717cantrell_aytubio.xml","form_type":"4"}},{"id":4379282,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option Grant","published_at":"2017-03-17T20:22:22.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These two transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vests on September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Grantee's continued service as a director on such dates."}],"balance_after":15000,"derivative":{"exercise_price":0.82,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001638599-17-000293","document":"doc4_4623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000293/doc4_4623.xml","form_type":"4"}},{"id":4379281,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option Grant","published_at":"2017-03-17T20:22:22.000Z","date":"2017-03-16","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These two transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vests on September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Grantee's continued service as a director on such dates."}],"balance_after":0,"derivative":{"exercise_price":3.23,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001638599-17-000293","document":"doc4_4623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000293/doc4_4623.xml","form_type":"4"}},{"id":4394503,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common STock","published_at":"2017-03-08T21:40:19.000Z","date":"2017-02-27","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6,"exercise_date":"2016-05-06","expiration_date":"2021-05-06","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001638599-17-000261","document":"doc4a_4598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000261/doc4a_4598.xml","form_type":"4/A","original_submission_date":"2017-03-01"}},{"id":4394502,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-03-08T21:40:19.000Z","date":"2017-02-27","kind":"exercise","acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.86,"exercise_date":"2017-11-02","expiration_date":"2021-11-02","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001638599-17-000261","document":"doc4a_4598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000261/doc4a_4598.xml","form_type":"4/A","original_submission_date":"2017-03-01"}},{"id":4394501,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-08T21:40:19.000Z","date":"2017-02-27","kind":"exercise","acquired":true,"shares":37083,"price":0.75,"value":27812.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Of these shares, 65,000 are restricted shares that vest on July 12, 2026, subject to earlier vesting in certain situations."}],"balance_after":135416,"source":{"system":"sec-edgar","filing":"0001638599-17-000261","document":"doc4a_4598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000261/doc4a_4598.xml","form_type":"4/A","original_submission_date":"2017-03-01"}},{"id":4413322,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common STock","published_at":"2017-03-01T23:47:00.000Z","date":"2017-02-27","kind":"exercise","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6,"exercise_date":"2016-05-06","expiration_date":"2021-05-06","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001638599-17-000231","document":"doc4_4572.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000231/doc4_4572.xml","form_type":"4"}},{"id":4413321,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-03-01T23:47:00.000Z","date":"2017-02-27","kind":"exercise","acquired":true,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.86,"exercise_date":"2017-11-02","expiration_date":"2021-11-02","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001638599-17-000231","document":"doc4_4572.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000231/doc4_4572.xml","form_type":"4"}},{"id":4413320,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-01T23:47:00.000Z","date":"2017-02-27","kind":"exercise","acquired":true,"shares":37083,"price":0.75,"value":27812.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Of these shares, 65,000 are restricted shares that vest on July 12, 2026, subject to earlier vesting in certain situations."}],"balance_after":135416,"source":{"system":"sec-edgar","filing":"0001638599-17-000231","document":"doc4_4572.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000231/doc4_4572.xml","form_type":"4"}},{"id":4566469,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2016-11-04T20:58:11.000Z","date":"2016-11-02","kind":"purchase","acquired":true,"shares":33333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of stock and warrants were purchased at a purchase price per unit of $1.50."}],"balance_after":33333,"derivative":{"exercise_price":1.86,"exercise_date":"2017-11-02","expiration_date":"2021-11-02","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001638599-16-001509","document":"doc4_4288.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859916001509/doc4_4288.xml","form_type":"4"}},{"id":4566468,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":121318,"kind":"person","name":"Cantrell Gary","position":1,"cik":"0001679246","reported_name":"Cantrell Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-04T20:58:11.000Z","date":"2016-11-02","kind":"purchase","acquired":true,"shares":33333,"price":1.5,"value":49999.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of stock and warrants were purchased at a purchase price per unit of $1.50."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of these shares, 65,000 are restricted shares that vest on July 12, 2026, subject to earlier vesting in certain situations."}],"balance_after":98333,"source":{"system":"sec-edgar","filing":"0001638599-16-001509","document":"doc4_4288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859916001509/doc4_4288.xml","form_type":"4"}}]}